Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Betty Raman; Mark Philip Cassar; Elizabeth M Tunnicliffe; Nicola Filippini; Ludovica Griffanti; Fidel Alfaro-Almagro; Thomas Okell; Fintan Sheerin; Cheng Xie; Masliza Mahmod; Ferenc E Mózes; Adam J Lewandowski; Eric O Ohuma; David Holdsworth; Hanan Lamlum; Myles J Woodman; Catherine Krasopoulos; Rebecca Mills; Flora A Kennedy McConnell; Chaoyue Wang; Christoph Arthofer; Frederik J Lange; Jesper Andersson; Mark Jenkinson; Charalambos Antoniades; Keith M Channon; Mayooran Shanmuganathan; Vanessa M Ferreira; Stefan K Piechnik; Paul Klenerman; Christopher Brightling; Nick P Talbot; Nayia Petousi; Najib M Rahman; Ling-Pei Ho; Kate Saunders; John R Geddes; Paul J Harrison; Kyle Pattinson; Matthew J Rowland; Brian J Angus; Fergus Gleeson; Michael Pavlides; Ivan Koychev; Karla L Miller; Clare Mackay; Peter Jezzard; Stephen M Smith; Stefan Neubauer

doi:10.1016/j.eclinm.2020.100683

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

EClinicalMedicine. 2021 Jan 7:31:100683. doi: 10.1016/j.eclinm.2020.100683. eCollection 2021 Jan.

Authors

Betty Raman^{1

2}, Mark Philip Cassar¹, Elizabeth M Tunnicliffe¹, Nicola Filippini³, Ludovica Griffanti^{3

4}, Fidel Alfaro-Almagro⁴, Thomas Okell⁴, Fintan Sheerin⁵, Cheng Xie^{5

6}, Masliza Mahmod¹, Ferenc E Mózes⁷, Adam J Lewandowski¹, Eric O Ohuma⁸, David Holdsworth⁹, Hanan Lamlum¹, Myles J Woodman¹, Catherine Krasopoulos¹, Rebecca Mills¹, Flora A Kennedy McConnell¹⁰, Chaoyue Wang⁴, Christoph Arthofer⁴, Frederik J Lange⁴, Jesper Andersson⁴, Mark Jenkinson⁴, Charalambos Antoniades^{1

2}, Keith M Channon^{1

2}, Mayooran Shanmuganathan¹, Vanessa M Ferreira¹, Stefan K Piechnik¹, Paul Klenerman¹¹, Christopher Brightling¹², Nick P Talbot⁹, Nayia Petousi¹¹, Najib M Rahman¹¹, Ling-Pei Ho¹³, Kate Saunders¹⁴, John R Geddes¹⁴, Paul J Harrison¹⁴, Kyle Pattinson¹⁵, Matthew J Rowland¹⁵, Brian J Angus¹⁶, Fergus Gleeson¹⁷, Michael Pavlides^{1

18}, Ivan Koychev¹⁵, Karla L Miller⁴, Clare Mackay^{3

15}, Peter Jezzard⁴, Stephen M Smith⁴, Stefan Neubauer^{1

2}

Affiliations

¹ Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, United Kingdom.
² Radcliffe Department of Medicine, British Heart Foundation Centre for Research Excellence, University of Oxford, Oxford, United Kingdom.
³ Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
⁴ Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
⁵ Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
⁶ Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
⁷ Oxford Centre for Clinical Magnetic Resonance Research, Radcliffe Department of Medicine, John Radcliffe Hospital Oxford, University of Oxford, Oxford, United Kingdom.
⁸ Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
⁹ Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
¹⁰ Division of Clinical Neuroscience, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, United Kingdom.
¹¹ Nuffield Department of Medicine, NIHR Oxford BRC, University of Oxford, Oxford, United Kingdom.
¹² Institute for Lung Health, Department of Respiratory Sciences, NIHR Leicester BRC, University of Leicester, Leicester, United Kingdom.
¹³ Weatherall Institute of Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
¹⁴ Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
¹⁵ Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
¹⁶ Experimental Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
¹⁷ Department of Oncology, Medical Science Department, University of Oxford, Oxford, United Kingdom.
¹⁸ Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Abstract

Background: The medium-term effects of Coronavirus disease (COVID-19) on organ health, exercise capacity, cognition, quality of life and mental health are poorly understood.

Methods: Fifty-eight COVID-19 patients post-hospital discharge and 30 age, sex, body mass index comorbidity-matched controls were enrolled for multiorgan (brain, lungs, heart, liver and kidneys) magnetic resonance imaging (MRI), spirometry, six-minute walk test, cardiopulmonary exercise test (CPET), quality of life, cognitive and mental health assessments.

Findings: At 2-3 months from disease-onset, 64% of patients experienced breathlessness and 55% reported fatigue. On MRI, abnormalities were seen in lungs (60%), heart (26%), liver (10%) and kidneys (29%). Patients exhibited changes in the thalamus, posterior thalamic radiations and sagittal stratum on brain MRI and demonstrated impaired cognitive performance, specifically in the executive and visuospatial domains. Exercise tolerance (maximal oxygen consumption and ventilatory efficiency on CPET) and six-minute walk distance were significantly reduced. The extent of extra-pulmonary MRI abnormalities and exercise intolerance correlated with serum markers of inflammation and acute illness severity. Patients had a higher burden of self-reported symptoms of depression and experienced significant impairment in all domains of quality of life compared to controls (p<0.0001 to 0.044).

Interpretation: A significant proportion of patients discharged from hospital reported symptoms of breathlessness, fatigue, depression and had limited exercise capacity. Persistent lung and extra-pulmonary organ MRI findings are common in patients and linked to inflammation and severity of acute illness.

Funding: NIHR Oxford and Oxford Health Biomedical Research Centres, British Heart Foundation Centre for Research Excellence, UKRI, Wellcome Trust, British Heart Foundation.

Keywords: COVID-19; Coronavirus; Follow up; Magnetic Resonance Imaging; Medium term; Mental health; Multiorgan effects; Post-hospital discharge; SARS-CoV-2 infection; Survivors.

Abstract

Grants and funding